Literature DB >> 18779189

Are you fluent in the language of dyspnea?

Donald A Mahler1, John C Baird2.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18779189     DOI: 10.1378/chest.08-1141

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  1 in total

1.  Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US.

Authors:  Krithika Rajagopalan; Lisa Bloudek; Jessica Marvel; Carole Dembek; Abhishek Kavati
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.